Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.19 | -10.02% | 3.18% | 332,278.86 | 2.35% | -19.03% |
|
NYSE:TMO
Thermo Fisher Scientific
|
595.30 | -17.43% | -8.17% | 227,235.73 | 0.26% | 14.15% |
|
SWX:ROG
Roche Holding
|
237.10 | 25.34% | 40.63% | 191,277.25 | 4.05% | 0.43% |
|
SWX:NOVN
Novartis
|
93.37 | 8.15% | 21.52% | 190,512.74 | 3.53% | 4.67% |
|
NYSE:DHR
Danaher
|
265.80 | -20.56% | -10.01% | 196,874.48 | 0.4% | 10.89% |
|
NasdaqGS:ILMN
Illumina
|
111.07 | 0% | 0% | 17,688.5 | 0% | -34.68% |
|
ENXTPA:ERF
Eurofins Scientific
|
58.26 | 14% | 29.25% | 11,046.73 | 0.86% | 7.46% |
|
NasdaqGM:TBIO
Translate Bio
|
37.40 | 0% | 0% | 2,824.08 | 0% | 0% |
|
NasdaqGS:TWST
Twist Bioscience
|
47.01 | 0% | 0% | 2,399.49 | 0% | 0% |
|
SZSE:300676
BGI Genomics
|
41.30 | 0% | 0% | 15,606.53 | 0.24% | 38.06% |
|
SHSE:688315
Novogene
|
14.39 | 0% | 0% | 5,905.54 | 0.33% | -11.81% |
|
NasdaqGM:CVAC
CureVac N.V.
|
3.49 | 0% | 0% | 564.45 | 0% | 0% |
|
AIM:MXCT
MaxCyte
|
3.75 | 0% | 0% | 303.18 | 0% | 0% |
|
NasdaqGS:PGEN
Precigen
|
1.38 | 0% | 0% | 345.81 | 0% | 0% |
|
NasdaqCM:APDN
Applied DNA Sciences
|
2.51 | 0% | 0% | 2.17 | 0% | 0% |
